ctrl K

Mineralys Therapeutics In... (MLYS)

NASDAQ: MLYS · Real-Time Price · USD

14.95

0.74 (5.21%)

At close: May 01, 2025, 3:59 PM

14.96

0.10%

After-hours: May 01, 2025, 04:05 PM EDT

Mineralys Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a
Operating Income	-192.4M	-84.66M	-31.48M	-18.73M	-2.94M
Interest Income	n/a	12.76M	1.68M	n/a	n/a
Pretax Income	-177.81M	-71.9M	-29.8M	-19.41M	-3.43M
Net Income	-177.81M	-71.9M	-29.8M	-19.41M	-3.43M
Selling & General & Admin	23.82M	14.3M	5.23M	2.42M	532K
Research & Development	168.58M	70.36M	26.25M	16.31M	2.41M
Other Expenses	n/a	n/a	4K	1K	-1K
Operating Expenses	192.4M	84.66M	31.48M	18.73M	2.94M
Interest Expense	n/a	n/a	1.68M	27K	115K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	84.66M	31.48M	18.73M	2.94M
Income Tax Expense	n/a	n/a	-1.9M	27K	115K
Shares Outstanding (Basic)	48.54M	36.19M	40.86M	39.06M	39.06M
Shares Outstanding (Diluted)	48.54M	36.19M	40.86M	39.06M	39.06M
EPS (Basic)	-3.66	-1.99	-0.73	-0.5	-0.09
EPS (Diluted)	-3.66	-1.99	-0.73	-0.5	-0.09
EBITDA	-192.4M	-84.66M	-31.48M	n/a	n/a
EBIT	n/a	-84.66M	-31.48M	-19.38M	-3.31M
Depreciation & Amortization	n/a	n/a	228.49K	18.73M	2.94M